Evolus Inc (EOLS) - News Archive

Evolus Expands Global Footprint with Multifaceted Initiatives in Aesthetic Medicine NEWPORT BEACH, Calif. Evolus, Inc. (NASDAQ: EOLS), a distinguished player in the performance beauty sector, has made significant stride...

In a decisive move to bolster its financial standing, Evolus Inc. (NASDAQ: EOLS), a Newport Beach-based performance beauty company, has announced the successful refinancing of its credit facilities, transitioning from a...

Evolus: Achieving New Heights in Aesthetic Medicine A Look at 2024 Financials and Strategic Initiatives In a year marked by unprecedented growth and strategic advancements, Evolus, Inc. (NASDAQ: EOLS) shines as a beacon...

Evolus Reports Record Preliminary Revenue Figures for Q4 and Full-Year 2024 Amid Market Underperformance Evolus, Inc. (NASDAQ: EOLS), headquartered in Newport Beach, California, has announced its preliminary, unaudited...

Expanding Horizons in Aesthetic Medicine: The Regulatory Milestones of Evolus and the Launch of Estyme Injectable Hyaluronic Acid Gels In the burgeoning field of aesthetic medicine, regulatory advancements and innovativ...

Evolus Inc.: A Dynamic Future in Performance Beauty Unfolds with Upcoming Investor Day and Positive Pivotal Study Results In the ever-evolving realm of aesthetics and consumer beauty, Evolus, Inc. (NASDAQ: EOLS) emerges...

Newport Beach, Calif. - Evolus, Inc. (NASDAQ: EOLS), a performance beauty company dedicated to creating a portfolio of aesthetic consumer brands, has made a significant stride in its strategic growth plan. The company a...

Promising Results of Evolus Evolysse Dermal Filler Products: A Breakthrough in Nasolabial Fold Treatment Evolus, Inc., a renowned performance beauty company, recently announced the positive topline results from a pivota...

Evolus, Inc., a leading performance beauty company focused on developing a portfolio of aesthetic consumer brands, has recently announced its financial results for the first quarter ended March 31, 2024. Following a rec...

Evolus, Inc. (NASDAQ: EOLS), a renowned performance beauty company focused on developing an aesthetic portfolio of consumer brands, has recently revealed the results from its European head-to-head filler trial. The comp...

In yet another move to solidify its position as a leading performance beauty company, Evolus Inc. has recently granted non-qualified stock options and restricted stock units (RSUs) to six newly hired non-executive emplo...

IntroductionEvolus Inc., a performance beauty company dedicated to developing a robust aesthetic portfolio of consumer brands, has recently announced the appointment of Nareg Sagherian as Vice President, Head of Global...

Evolus Inc, a prominent performance beauty company, recently made a press release reporting the grant of non-qualified stock options and restricted stock units (RSUs) to new non-executive employees. This article aims to...

Evolus Inc., a performance beauty company, recently presented compelling data at the 2023 American Society for Dermatologic Surgery (ASDS) Annual Meeting, showcasing the extended duration effects of their extra-strength...